STING1 and neoplasm: To rule out potential off-target effects from CRISPR–Cas9-mediated KO, we depleted Sting1 using short hairpin RNA (shRNA) and observed a similar reduction in lung metastasis with no impact on primary tumour formation (Fig. 1g–i and Extended Data Fig. 1k).